| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract
|
Theodore, C.
|
|
|
17 |
6 |
p. 990-994
|
artikel
|
| 2 |
A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)
|
Kollmannsberger, C.
|
|
|
17 |
6 |
p. 1007-1013
|
artikel
|
| 3 |
Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer: results of a multicenter phase-II trial
|
Sehouli, J.
|
|
|
17 |
6 |
p. 957-961
|
artikel
|
| 4 |
Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment
|
Schmoll, H.J.
|
|
|
17 |
6 |
p. 1000-1006
|
artikel
|
| 5 |
Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors
|
Italiano, A.
|
|
|
17 |
6 |
p. 981-985
|
artikel
|
| 6 |
Concurrent oxaliplatin, capecitabine, and radiation therapy in the neoadjuvant therapy of rectal adenocarcinoma: can we get the right dose first?
|
Fakih, M.G.
|
|
|
17 |
6 |
p. 1029-1030
|
artikel
|
| 7 |
Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer
|
Weinfurt, K.P.
|
|
|
17 |
6 |
p. 986-989
|
artikel
|
| 8 |
EGFR in colorectal cancer: more than a simple receptor
|
Francoual, M.
|
|
|
17 |
6 |
p. 962-967
|
artikel
|
| 9 |
EGFR mutation in gefitinib-responsive small-cell lung cancer
|
Okamoto, I.
|
|
|
17 |
6 |
p. 1028-1029
|
artikel
|
| 10 |
Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer
|
Andre, F.
|
|
|
17 |
6 |
p. 945-951
|
artikel
|
| 11 |
Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study
|
Hentrich, M.
|
|
|
17 |
6 |
p. 914-919
|
artikel
|
| 12 |
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
|
Pestalozzi, B.C.
|
|
|
17 |
6 |
p. 935-944
|
artikel
|
| 13 |
in this issue
|
|
|
|
17 |
6 |
p. 881
|
artikel
|
| 14 |
Is there a place for routine imaging for patients in complete remission from aggressive lymphoma?
|
Armitage, J.O.
|
|
|
17 |
6 |
p. 883-884
|
artikel
|
| 15 |
Management of the adverse effects associated with intravenous bisphosphonates
|
Tanvetyanon, T.
|
|
|
17 |
6 |
p. 897-907
|
artikel
|
| 16 |
Measuring tumor response and shape change on CT: esophageal cancer as a paradigm
|
Schwartz, L.H.
|
|
|
17 |
6 |
p. 1018-1023
|
artikel
|
| 17 |
Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer
|
Demokan, S.
|
|
|
17 |
6 |
p. 995-999
|
artikel
|
| 18 |
Molecular stool testing for the early detection of colorectal cancer: swan song for p53?
|
Ferretti, G.
|
|
|
17 |
6 |
p. 1026
|
artikel
|
| 19 |
Non-Hodgkin's lymphoma in patients 80 years of age or older
|
Bairey, O.
|
|
|
17 |
6 |
p. 928-934
|
artikel
|
| 20 |
Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience
|
Ganti, A.K.
|
|
|
17 |
6 |
p. 920-927
|
artikel
|
| 21 |
Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer
|
Goto, A.
|
|
|
17 |
6 |
p. 968-973
|
artikel
|
| 22 |
Problems of opioid availability and accessibility across Europe: ESMO tackles the regulatory causes of intolerable and needless suffering
|
Cherny, N.I.
|
|
|
17 |
6 |
p. 885-887
|
artikel
|
| 23 |
Rapid-infusion rituximab in lymphoma treatment
|
Provencio, M.
|
|
|
17 |
6 |
p. 1027-1028
|
artikel
|
| 24 |
Reply to Letter to the Editor ‘Concurrent oxaliplatin, capecitabine, and radiation therapy in the neoadjuvant therapy of rectal adenocarcinoma: can we get the right dose first?’, by M. G. Fakih (Ann Oncol 2006; 17: 1029)
|
Machiels, J.-P.
|
|
|
17 |
6 |
p. 1030-1031
|
artikel
|
| 25 |
Secondary acute promyelocytic leukemia following irinotecan and oxaliplatin for advanced colon cancer
|
Merrouche, Y.
|
|
|
17 |
6 |
p. 1025-1026
|
artikel
|
| 26 |
Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer
|
Bravi, F.
|
|
|
17 |
6 |
p. 1014-1017
|
artikel
|
| 27 |
Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population
|
Liedtke, M.
|
|
|
17 |
6 |
p. 909-913
|
artikel
|
| 28 |
Table of Contents
|
|
|
|
17 |
6 |
p. iv-v
|
artikel
|
| 29 |
Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada – Clinical Trials Group (NCIC-CTG)
|
Trudeau, M.E.
|
|
|
17 |
6 |
p. 952-956
|
artikel
|
| 30 |
The advisory process for anticancer drug regulation: a global perspective
|
Farrell, A.T.
|
|
|
17 |
6 |
p. 889-896
|
artikel
|
| 31 |
Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests
|
Lesterhuis, W.J.
|
|
|
17 |
6 |
p. 974-980
|
artikel
|
Tijdschrift beschrijving